NARDONE, OLGA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 746
AS - Asia 479
EU - Europa 353
AF - Africa 20
OC - Oceania 1
SA - Sud America 1
Totale 1.600
Nazione #
US - Stati Uniti d'America 732
SG - Singapore 211
IT - Italia 203
HK - Hong Kong 170
CN - Cina 80
NL - Olanda 48
DE - Germania 23
FI - Finlandia 21
IE - Irlanda 20
CI - Costa d'Avorio 18
CA - Canada 14
BG - Bulgaria 12
GB - Regno Unito 8
IN - India 8
RU - Federazione Russa 5
SE - Svezia 4
VN - Vietnam 4
EG - Egitto 2
FR - Francia 2
JP - Giappone 2
LT - Lituania 2
BE - Belgio 1
BO - Bolivia 1
DK - Danimarca 1
ID - Indonesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
RS - Serbia 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.600
Città #
Hong Kong 170
Singapore 167
Chandler 164
Santa Clara 82
Naples 51
Amsterdam 45
Ashburn 34
Millbury 26
Napoli 26
Beijing 25
Seattle 16
Nanjing 15
Des Moines 14
Boardman 13
Sofia 12
Princeton 11
Lawrence 10
Redwood City 10
Rome 8
Boston 7
Helsinki 7
Milan 7
Ottawa 7
Toronto 7
Wilmington 7
Dublin 6
Kronberg 6
Los Angeles 6
Jiaxing 5
Lappeenranta 5
Clifton 4
Dong Ket 4
Falls Church 4
Nocera Inferiore 4
Turin 4
Agropoli 3
Castel San Pietro Terme 3
Frankfurt am Main 3
Hebei 3
Nanchang 3
Perugia 3
Rohtak 3
Zhengzhou 3
Acerra 2
Andover 2
Cagliari 2
Changsha 2
Chengdu 2
Council Bluffs 2
Damietta 2
Esslingen am Neckar 2
Hengoed 2
Indore 2
Jinan 2
London 2
Melito di Napoli 2
Pune 2
Salem 2
Shenyang 2
Storo 2
Taizhou 2
Yokohama 2
Augusta 1
Bollate 1
Brussels 1
Cambridge 1
Capri 1
Charlestown 1
Citta 1
College Station 1
Dallas 1
Dunedin 1
Fairfield 1
Falkenstein 1
Fisciano 1
Fort Worth 1
Fremont 1
Gesualdo 1
Hangzhou 1
Islamabad 1
Jakarta 1
Kaunas 1
Krefeld 1
Kunming 1
La Paz 1
Mainz 1
Marcianise 1
Montecorvino Rovella 1
Moscow 1
Nashville 1
New Delhi 1
New Orleans 1
Ningbo 1
Nuremberg 1
Pioltello 1
Pozzuoli 1
Qingdao 1
San Felice A Cancello 1
San Francisco 1
San Mateo 1
Totale 1.089
Nome #
Bowel damage in Crohn's disease: direct comparison of ultrasonography- and magnetic resonance-based Lemann index. 69
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents 67
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with biologics 62
Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease 62
Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index 59
Successful outcome of the transitional process of inflammatory bowel disease from pediatric to adult age: A five years experience 56
Efficacy of a "contact center-based communication" in optimizing the care of inflammatory bowel diseases 53
Multi-detector CT enterography in active inflammatory bowel disease: Image quality and diagnostic efficacy of a low-radiation high contrast protocol 53
The burden of anaemia in patients with inflammatory bowel diseases 47
Adherence in ulcerative colitis: an overview 47
Gut microbiota and Crohn's disease 45
Diagnostic Accuracy of Ultrasonography in the Detection of Postsurgical Recurrence in Crohn's Disease: A Systematic Review with Meta-analysis 44
The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease 43
Different profile of efficacy of thiopurines in ulcerative colitis and Crohn's disease 43
Combined endoscopic/sonographic-based risk matrix model for predicting one-year risk of surgery: A prospective observational study of a tertiary centre severe/refractory crohn's disease cohort 42
One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing. 38
Psoriasis Features in Patients with Inflammatory Bowel Disease 36
The impact of a dedicated contact centre on the clinical outcome of patients with inflammatory bowel disease during the COVID-19 outbreak 32
Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease care models? 31
Exclusive Enteral Nutrition in Adult Crohn’s Disease: an Overview of Clinical Practice and Perceived Barriers 31
Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure 28
David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's Disease 27
Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold 25
Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn's Disease Patients Undergoing Multidetector CT-Enterography 25
Gut microbiota and irritable bowel syndrome 25
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 24
Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world setting. 23
The Impact of Intestinal Ultrasound on the Management of Inflammatory Bowel Disease: From Established Facts Toward New Horizons 23
Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era 22
Objective comparison of vedolizumab and ustekinumab effectiveness in Crohn's disease patients failure to TNF-alpha inhibitors 21
Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives 20
Lactose intolerance assessed by analysis of genetic polymorphism, breath test and symptoms in patients with inflammatory bowel disease 19
Time to grow up: readiness associated with improved clinical outcomes in pediatric inflammatory bowel disease patients undergoing transition 18
Exploring the concept of deep remission in Crohn's disease: correlation between transmural healing and biomarkers 16
Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy 15
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 15
A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis 15
Reproducibility of the electronic chromoendoscopy PICaSSO score (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis using multiple endoscopic platforms: a prospective multicenter international study (with video) 14
New endoscopic tools in inflammatory bowel disease 13
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 13
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 13
Rates of Endoscopic Recurrence In Postoperative Crohn's Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis 12
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?-Author's reply 12
Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study 11
Small molecule oral targeted therapies in ulcerative colitis 11
Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative 11
Real-world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey 11
Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life 11
Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis 10
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey 10
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study 10
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year 10
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 10
Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease 10
Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease? 9
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 9
Image-Enhanced Endoscopy Surveillance of Colon and Pouch Dysplasia in IBD 9
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection 8
Prevalence of Sexual Dysfunction in Inflammatory Bowel Disease: Systematic Review and Meta-analysis 8
Image-Enhanced Endoscopy in the Surveillance of Colitis-Associated Neoplasia 8
Neutrophil-only histological assessment of ulcerative colitis correlates with endoscopic activity and predicts long-term outcomes in a multicenter study 8
Effectiveness of Partial Enteral Nutrition as Add-On to Biologics in Patients With Refractory and Difficult-to-Treat Crohn’s Disease: A Pilot Study 8
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis 7
Insights into disability and psycho-social care of patients with inflammatory bowel disease 7
Addressing unmet needs of gastroenterologists' training in the post-COVID-19 era 7
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab 7
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists 7
Sarcopenia: A new route on the map for risk stratification in inflammatory bowel disease 7
Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy 7
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey 7
Endocytoscopy with automated multispectral intestinal barrier pathology imaging for assessment of deep healing to predict outcomes in ulcerative colitis 7
Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey 7
Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients 7
MMX mesalamine: A modern twist on a classic treatment 6
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis 6
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis 6
Heterogeneity of definition of upper gastrointestinal tract in different guidelines of Crohn's disease: A scoping review 6
Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission 6
AI and endoscopy/histology in UC: the rise of machine 6
Advancing perioperative optimization in Crohn's disease surgery with machine learning predictions 5
Predicting Outcome after Acute Severe Ulcerative Colitis: A Contemporary Review and Areas for Future Research 5
Key challenges and care approaches in inflammatory pouch disorders: What can we do better? 5
Efficacy and safety of Advanced Combination Treatment in immune-mediated inflammatory disease: A systematic review and meta-analysis of randomized controlled trials 5
Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter study 4
Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring 3
Totale 1.720
Categoria #
all - tutte 8.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.904


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202052 0 0 0 0 0 0 9 4 1 10 23 5
2020/202153 2 1 1 1 10 7 3 5 12 1 3 7
2021/2022183 0 0 2 2 1 2 0 9 12 12 52 91
2022/2023333 30 44 6 29 43 38 3 30 42 46 15 7
2023/2024335 7 35 15 15 10 28 62 45 6 5 69 38
2024/2025601 108 101 6 16 65 108 197 0 0 0 0 0
Totale 1.720